Free hemoglobin determination at patients' bedside to evaluate hemolysis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Bioanalysis Année : 2023

Free hemoglobin determination at patients' bedside to evaluate hemolysis

Résumé

Background: The authors report the relevance of using a point of care test (Helge ® ) for free hemoglobin determination and concordance of the values the with Cobas ® 8000 and spectrophotometer methods. Results: The within-run of the point of care test was <3%. Good correlations among the three methods were observed and an acceptable concordance for hemolysis index values from 50 mg/dl. An excellent agreement between the Cobas 8000 and the spectrophotometer was found. Conclusion: Automated methods represent methods of choice for free hemoglobin determination. An advantage of the Helge system is that it can be applied to samples experiencing a delay in evaluation due to the long distance between the collection site and the central laboratory. Another advantage is its use at the bedside, in the monitoring of extracorporeal membrane oxygenation patients.
Fichier non déposé

Dates et versions

hal-04331261 , version 1 (08-12-2023)

Identifiants

Citer

Bastien Baud, Anne Marie Dupuy, Samuel Zozor, Stéphanie Badiou, Anne Sophie Bargnoux, et al.. Free hemoglobin determination at patients' bedside to evaluate hemolysis. Bioanalysis, 2023, ⟨10.4155/bio-2023-0116⟩. ⟨hal-04331261⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More